Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients
详细信息 查看全文
- 作者：Inayat U Rahman ; Rooh Ullah Khan ; Khalil Ur Rahman ; Mohammad Bashir
- 关键词：Bitter melon ; Glibenclamide ; Type 2 diabetics ; Glycemic control ; Cardiovascular risk factors
- 刊名：Nutrition Journal
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：14
- 期：1
- 全文大小：311 KB
- 刊物类别：Chemistry and Materials Science
- 刊物主题：Nutrition
Clinical Nutrition - 出版者：BioMed Central
- ISSN：1475-2891
文摘
Objective Since antiquity bitter melon has been in use for treating diabetes but clinical trials show conflicting results about its usefulness. The present study aims to asses and compare the hypoglycemic and antiatherogenic effects as well as the safety of two different doses of bitter melon with glibenclamide.